|
PPP1R9A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.5848000000005E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.958900E-04 |
| Normal-vs-Stage2 |
1.699000E-01 |
| Normal-vs-Stage3 |
4.971600E-01 |
| Normal-vs-Stage4 |
4.024400E-01 |
| Stage1-vs-Stage2 |
4.829800E-01 |
| Stage1-vs-Stage3 |
2.156200E-03 |
| Stage1-vs-Stage4 |
7.200900E-04 |
| Stage2-vs-Stage3 |
1.289770E-01 |
| Stage2-vs-Stage4 |
1.206960E-01 |
| Stage3-vs-Stage4 |
9.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.45170000000062E-05 |
| Normal-vs-AfricanAmerican |
3.181900E-02 |
| Normal-vs-Asian |
8.038000E-01 |
| Caucasian-vs-AfricanAmerican |
7.960200E-01 |
| Caucasian-vs-Asian |
4.320600E-01 |
| AfricanAmerican-vs-Asian |
5.518800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.637090E-04 |
| Normal-vs-Female |
4.496300E-03 |
| Male-vs-Female |
3.791200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.213000E-01 |
| Normal-vs-Extreme_Weight |
1.800300E-02 |
| Normal-vs-Obese |
7.339000E-03 |
| Normal-vs-Extreme_Obese |
2.685200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.203000E-01 |
| Normal_Weight-vs-Obese |
7.283800E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.372200E-01 |
| Extreme_Weight-vs-Obese |
2.742000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.886600E-01 |
| Obese-vs-Extreme_Obese |
6.198400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.639700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.23029999999458E-05 |
| Normal-vs-Age(61-80Yrs) |
7.558400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.294800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.896600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.286400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.714770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.399200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.742010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.014800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.21200005376699E-09 |
| Normal-VS-Type2 PRCC |
2.364800E-01 |
| Normal-VS-KIRP CIMP |
3.123000E-01 |
| Normal-VS-Unclassified PRCC |
3.014400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.97169955310039E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.375500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.728400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.947000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.275100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.649900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.041600E-01 |
| Normal-vs-N1 |
3.765800E-01 |
| Normal-vs-N2 |
7.638600E-01 |
| N0-vs-N1 |
3.567600E-01 |
| N0-vs-N2 |
8.074600E-01 |
| N1-vs-N2 |
8.116400E-01 |
|
|
